Why are MPs concerned about Palantir’s role in the NHS?

MPs say reports of Palantir staff accessing identifiable patient data before pseudonymisation raise serious privacy concerns and could damage public confidence in the NHS.

What is the data being used for?

Reports indicate the access relates to an integrated platform intended to help the NHS use data and AI tools to improve how the health service operates.

Why does pseudonymisation matter here?

Pseudonymisation reduces the ability to link data directly to individual patients, so allowing access before that step increases sensitivity and heightens privacy concerns.

MPs Warn on Palantir NHS Data Access

A fight over patient privacy has broken into the open at the heart of the NHS. MPs say Palantir’s reported access to identifiable data could deepen public distrust just as AI ambitions expand.

MPs have accused NHS England of taking a dangerous step by reportedly allowing Palantir staff to access identifiable patient data before it was pseudonymised.

The warning cuts to the center of a growing battle over how far the health service should go in using private tech firms and artificial intelligence to reshape care. Reports indicate NHS England granted the US company and other contractors broad access as part of a project to build an integrated data platform designed to improve how the service runs. Critics argue that the issue is not only who can see the data, but when they can see it and under what safeguards.

MPs say the reported decision risks reinforcing public fears that patient privacy is slipping behind the NHS push for AI and data-driven reform.

The concern goes beyond technical compliance. According to reports, internal discussions had already flagged a risk of losing public confidence if outside contractors handled patient information before anonymisation measures took effect. That fear now appears to be driving the political response, with MPs warning that trust, once damaged, will prove far harder to rebuild than any digital platform.

Key Facts

MPs have described Palantir’s reported access to identifiable NHS patient data as dangerous.
Reports suggest NHS England allowed Palantir staff and other contractors to view data before pseudonymisation.
The access relates to work on an integrated platform intended to support AI and service improvement.
Internal concerns reportedly included a possible loss of public confidence over data privacy.

The row also sharpens wider questions about accountability in the NHS’s technology strategy. Supporters of large-scale data projects argue they can help hospitals plan better, spot pressure points faster and improve patient care. Opponents do not dispute the promise of better tools, but they argue the public will not accept innovation if officials appear to weaken basic privacy protections to get there.

What happens next will matter well beyond this single contract. MPs are likely to press for clearer answers on what access was granted, which safeguards applied and whether patients received enough protection as the NHS expanded its AI plans. The outcome could shape not only the future of Palantir’s role in the health service, but also the terms on which the NHS wins public consent for the next wave of data-driven reform.

MPs Warn on Palantir NHS Data Access

Key Facts

Frequently Asked Questions